Eulogio Pleguezuelos
Mataró, Barcelona, 08304, Spain
NCT Number: NCT01850173
The investigators designed the current study with the main objective of determining whether Whole Body Vibration Training (WBVT) alone improves muscular force and/or modifies the functional capacity parameters in severe Chronic Obstructive Pulmonary Disease (COPD) patients referred to a rehabilitation programme.
Looking for future studies?
Notify Me55 year–85 year
Male
Interventional
Not applicable
Mataró, Barcelona, 08304, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
They performed 6 series, and each series consisted of four 30-second repetitions with a frequency of 35 Hz and 2 millimeters of amplitude, with 60 seconds of rest between each series.
Time frame: basal, 3 months follow up
the change between basal - and 3 months follow up.
Time frame: Basal, 3 months follow up
the change between basal - and 3 months follow up.
Time frame: Basal, 3 month follow up
the change between basal - and 3 months follow up.
Time frame: 3 months follow up
cardiac events, increase in respiratory symptoms, knee pain during whole body vibration training.
Hospital de Mataró
Other
Effects of Whole Body Vibration Training in Severe Chronic Obstructive Pulmonary Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details